P

Inventor

BAMDAD CYNTHIA

US26 patents
⚠️ This page may combine multiple inventors who share the name “BAMDAD CYNTHIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MINERVA BIOTECHNOLOGIES CORP

25 patents
US11976132B2May 7, 2024

Diagnostic methods using anti-MUC1* antibodies

MINERVA BIOTECHNOLOGIES CORP5 citations85
US11746159B2Sep 5, 2023

Humanized anti-MUC1* antibodies

MINERVA BIOTECHNOLOGIES CORP8 citations84
US11591565B2Feb 28, 2023

Media for stem cell proliferation and induction

MINERVA BIOTECHNOLOGIES CORP5 citations84
US9932407B2Apr 3, 2018

Stem cell enhancing therapeutics

MINERVA BIOTECHNOLOGIES CORP8 citations84
US12195728B2Jan 14, 2025

Method for making pluripotent stem cells

MINERVA BIOTECHNOLOGIES CORP1 citations74
US12049618B2Jul 30, 2024

Method for making pluripotent stem cells

MINERVA BIOTECHNOLOGIES CORP3 citations74
US12115192B2Oct 15, 2024

Chimeric antigen receptor compositions and methods for treating MUC1* diseases

MINERVA BIOTECHNOLOGIES CORP3 citations73
US12049514B2Jul 30, 2024

Anti-NME antibody and method of treating cancer or cancer metastasis

MINERVA BIOTECHNOLOGIES CORP3 citations73
US12037413B2Jul 16, 2024

Anti-NME antibody and method of treating cancer or cancer metastasis

MINERVA BIOTECHNOLOGIES CORP3 citations73
US12006371B2Jun 11, 2024

Humanized anti-MUC1* antibodies

MINERVA BIOTECHNOLOGIES CORP3 citations73
US11976295B2May 7, 2024

Media for stem cell proliferation and induction

MINERVA BIOTECHNOLOGIES CORP4 citations73
US11897967B2Feb 13, 2024

Humanized anti-MUC1* antibodies

MINERVA BIOTECHNOLOGIES CORP3 citations73
US10724027B2Jul 28, 2020

Method for making pluripotent stem cells

MINERVA BIOTECHNOLOGIES CORP4 citations73
US10703821B2Jul 7, 2020

Method for stimulating or enhancing proliferation of cells by activating the mucin 1 (MUC1) receptor

MINERVA BIOTECHNOLOGIES CORP5 citations73
US11702483B2Jul 18, 2023

Method of treating an NME7 expressing cancer with a peptide

MINERVA BIOTECHNOLOGIES CORP2 citations72
US11931347B2Mar 19, 2024

Method of screening for agents for differentiating stem cells

MINERVA BIOTECHNOLOGIES CORP5 citations71
US11560435B2Jan 24, 2023

MUC1* antibodies

MINERVA BIOTECHNOLOGIES CORP4 citations70
US12104170B2Oct 1, 2024

Methods for deriving dopaminergic neurons from pluripotent stem cells

MINERVA BIOTECHNOLOGIES CORP2 citations65
US12351646B2Jul 8, 2025

Diagnostic methods using anti-MUC1* antibodies

MINERVA BIOTECHNOLOGIES CORP1 citations64
US12583927B2Mar 24, 2026

Anti-variable MUC1* antibodies and uses thereof

MINERVA BIOTECHNOLOGIES CORP0 citations61
US12479928B2Nov 25, 2025

Anti-cancer peptide

MINERVA BIOTECHNOLOGIES CORP0 citations61
US12202799B2Jan 21, 2025

Agents for differentiating stem cells and treating cancer

MINERVA BIOTECHNOLOGIES CORP2 citations61
US9649312B2May 16, 2017

Compositions and methods of treatment of cancer

MINERVA BIOTECHNOLOGIES CORP0 citations52
US12415868B1Sep 16, 2025

Anti-NME antibody and method of treating cancer or cancer metastasis

MINERVA BIOTECHNOLOGIES CORP0 citations51
US12491259B2Dec 9, 2025

Anti-variable MUC1* antibodies and uses thereof

MINERVA BIOTECHNOLOGIES CORP0 citations46

CLINICAL MIRCO SENSORS INC

1 patent